Modular Solution for Cosmetics Compliance
Check the Conformity of your Formulas
Secure your regulatory documents for each zone
Optimize on-site risk management
Manage your Safety Data Sheets efficiently
Automate your regulatory monitoring
Ensure the traceability of your substances
Maintain good HSE risk management
After more than twenty-five years of negotiations, the European Union and the Mercosur countries — Brazil, Argentina, Uruguay and Paraguay — finalized their trade agreement. Provisionally applied since 1 May 2026, the agreement marks a major step in economic relations between Europe and South America. For European companies in cosmetics, fragrance and home fragrance, the issue is twofold: benefiting from progressively improved commercial access to high-potential markets, while continuing to comply with regulatory requirements that remain largely national. Although the EU–Mercosur agreement creates new opportunities, it does not remove product registration obligations, labelling requirements or the need for a local responsible party in the countries concerned. For European brands, success will depend not only on commercial strategy, but also on early regulatory planning.
Recevez une fois par mois les dernières actus réglementaires et conseils d’experts.
Learn about the risks of non-compliance with the new medical devices regulation in Europe, including financial losses, damage to brand image, and sanctions by Member States. Understand evolving obligations and how to ensure compliance to avoid these risks.
The new Medical Device Regulation expands the scope to cover non-medical devices and changes device classifications. Notified Bodies are now under stricter control, leading to longer time to market. Economic operators have specific roles and obligations. Stricter rules for clinical evaluation and post-marketing monitoring. A unique identification system and EUDAMED database enhance traceability. Regulation 2017/745 aims to improve transparency and safety of medical devices in Europe.
The European Commission released an addendum clarifying banned claims in cosmetics for hand gels. The document provides a negative list of prohibited claims and images. Understanding the difference between cosmetic and biocidal products is crucial for marketing strategies. Consider the advantages of marketing a leave-on cleansing gel versus a hand disinfectant.
The European Commission's REACH Committee has approved the postponement of the authorisation deadlines for ethoxylated 4-(1,1,3,3-tetramethylbutyl)phenol, crucial for Covid-19 related medical products. The new deadlines extend the application and sunset dates by 18 and 36 months, respectively.
DGCCRF found 38% of hand sanitizers non-compliant, risking ineffectiveness against Covid-19. Learn how to ensure compliance with biocidal regulations to avoid product recalls.
Learn about UFIs, unique codes required on labels of hazardous mixtures. Deadlines for compliance are set for 2021 and 2024. Harmonised format for poison centre notifications is now mandatory in the EU.
